Havrix Adultes

Havrix Adultes is a hepatitis A vaccine containing inactivated hepatitis A virus and aluminium hydroxide as an adjuvant. It is supplied as an injectable solution for intramuscular administration. The product is authorized in the European Union and is prescribed (Rx) for adult patients to prevent hepatitis A infection. The vaccine is formulated to induce active immunity by stimulating the body’s antibody response and is typically stored under refrigeration.

Havrix Adultes is indicated for the prevention of hepatitis A virus infection in adults.

- Active immunization of individuals who have not been previously exposed to hepatitis A virus. - Protection of travelers to regions where hepatitis A is endemic or where outbreaks occur. - Immunization of people at increased risk due to occupational exposure, such as laboratory personnel handling hepatitis A specimens. - Use in outbreak control situations to rapidly increase population immunity.

Side effects reported after Havrix Adultes administration are generally mild and transient.

Common: - Pain, redness, or swelling at the injection site. - Low‑grade fever. - Headache. - Fatigue.

Serious: - Severe allergic reaction (anaphylaxis). - Guillain‑Barré syndrome (rare).

Precautions for Havrix Adultes focus on patient history and potential adverse reactions.

- Do not administer to individuals with a known severe allergy to any vaccine component. - Defer vaccination in persons experiencing an acute moderate or severe illness. - Counsel patients that mild local reactions are common and usually resolve without treatment. - Monitor for signs of anaphylaxis for at least 15 minutes after injection. - Use with caution in pregnant or breastfeeding women; discuss risk‑benefit with a healthcare professional.

Havrix Adultes has limited documented drug interactions, but certain situations warrant attention.

Avoid: - Concomitant administration of other vaccines containing live attenuated viruses without appropriate interval. - Use of immunosuppressive therapies that may diminish vaccine response.

Use with caution: - Antipyretics (e.g., acetaminophen) taken prophylactically may reduce antibody response; use only if needed for symptom relief. - Concurrent administration of blood products or immunoglobulins may interfere with vaccine efficacy. - Patients on chronic corticosteroid therapy should be evaluated for adequate immune response.